. disclaimer the website you have selected is an external one and you will now be leaving www.kadmon.com . kadmon has no responsibility for any external websites . we neither endorse the information content presentation or accuracy nor make any warranty express or implied regarding any external websites . continue to leave kadmon.com continue cancel loading menu s research & development discovery pipeline clinical trials products about us leadership team board of directors scientific advisory board corporate governance compliance news press releases publications media inquiries investors s x developing innovative medicines for significant unmet medical needs learn more pipeline our pipeline of novel drug candidates targets diseases with significant unmet medical need news kadmon initiates placebo controlled phase 2 clinical trial evaluating kd025 in psoriasis discovery with groundbreaking drug discovery platforms kadmon is creating the next generation of medicines investors kadmon maintains ongoing open dialogue with the investor community products we offer medicines for serious and rare diseases meet our innovators and industry leaders learn more learn more about our novel drug candidates see our pipeline find our press releases publications and events read more kadmon holdings inc. 450 east 29th street new york ny 10016 119 commonwealth drive warrendale pa 15086 55 cambridge parkway suite 300e cambridge ma 02142 1 deer park drive ste h 4 monmouth junction nj 08852 kadmon about us contact us pipeline careers kadmon holdings inc. copyright 2016 . all rights reserved . terms of use privacy policy california compliance